— Know what they know.
Not Investment Advice

MRUS NASDAQ

Merus N.V.
1W: -7.1% 1M: -6.2% 3M: -4.4% 1Y: +113.9% 3Y: +513.5% 5Y: +390.2%
$90.00
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $6.8B mcap · 70M float · 2.45% daily turnover · Short 55% of daily vol

Balance Sheet Trends

Total Assets
$785M +72.4% ▲
5Y CAGR: +24.4%
Total Liabilities
$135M +35.9% ▲
5Y CAGR: +0.4%
Shareholders Equity
$648M +81.8% ▲
5Y CAGR: +37.6%
Cash & Investments
$537M +51.2% ▲
5Y CAGR: +17.5%
Total Debt
$10M -18.5% ▼
5Y CAGR: +13.5%
Net Debt
-$283M -46.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$163M$241M$148M$205M$293M
Short-Term Investments$45M$169M$142M$150M$244M
Cash & ST Investments$208M$410M$290M$355M$537M
Net Receivables$2M$7M$5M$4M$5M
Inventory$0$0$0$0$0
Other Current Assets$1M$2M$2M$727K$2M
Total Current Assets$218M$424M$306M$369M$569M
Property, Plant & Equip.$8M$7M$25M$23M$20M
Goodwill & Intangibles$3M$2M$2M$2M$2M
Long-Term Investments$0$20M$36M$57M$187M
Other Non-Current Assets$2M$2M$5M$3M$953K
Total Non-Current Assets$13M$32M$70M$87M$214M
Total Assets$231M$457M$377M$455M$785M
— Liabilities —
Accounts Payable$3M$13M$10M$5M$4M
Short-Term Debt$0$0$0$0$2M
Deferred Revenue$20M$35M$29M$23M$30M
Other Current Liabilities$11K$1M$38K$35K$103K
Total Current Liabilities$47M$72M$79M$69M$87M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.-$1M$0$0$0$0
Total Non-Current Liabilities$82M$69M$51M$30M$48M
Total Liabilities$129M$140M$129M$99M$135M
— Equity —
Common Stock$3M$4M$5M$6M$7M
Retained Earnings-$400M-$467M-$598M-$753M-$968M
Accumulated OCI$9M-$9M-$30M-$23M-$55M
Total Stockholders Equity$102M$316M$247M$356M$648M
Total Liabilities & Equity$231M$457M$377M$455M$783M
— Key Metrics —
Total Debt$4M$4M$13M$12M$10M
Net Debt-$159M-$238M-$134M-$193M-$283M
Total Investments$45M$189M$179M$207M$431M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms